FDA Grand Rounds - Antibody Glycosylation Insights for High Quality Biotherapeutics

FDA Grand Rounds · February 5, 2026

0:00/37m

37:48

0:00

10:00

20:00

30:00

37:48

Opening and introduction of presenter

Presentation

0:00 → 1:25(1m 25s)

Moderator opened FDA Grand Rounds, introduced the day's presenter as Dr. Bao Lin Zhang and summarized his 25 years of FDA regulatory experience and academic background.

Keywords:

Speakers:Unidentified Moderator

Dr. Bao Lin Zhang presented FDA research on antibody glycosylation, sharing a benchmark of glycan profiles across FDA-approved therapeutic antibodies and describing a lectin microarray platform for rapid glycan-epitope profiling.

AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Transcript

Unlock the transcript with a paid subscription